Fate Therapeutics, Inc. (FATE) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Valamehr Bahram mit 664,708 Aktien. Weitere bedeutende Anteilseigner sind Wolchko J Scott und TAHL CINDY.
In den letzten 12 Monaten haben Insider 21 Transaktionen in FATE Aktien getätigt — 14 Käufe (im Wert von $1.3M) und 4 Verkäufe (im Wert von $41.8K). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
FATE Insider-Beteiligungen
Größter Aktionär
Valamehr Bahram
664,708 Aktien
Käufe (12 Monate)
14
$1.3M Wert
Verkäufe (12 Monate)
4
$41.8K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Valamehr Bahram |
President and CEO |
664,708 |
2026-01-16 |
|
| 2 |
Wolchko J Scott |
President and CEO |
500,000 |
2024-02-02 |
|
| 3 |
Tahl Cindy |
See Remarks |
400,000 |
2026-01-16 |
|
| 4 |
Bressi Jerome Charles |
See Remarks |
250,000 |
2025-01-16 |
|
| 5 |
Storgard Chris |
Chief Medical Officer |
186,000 |
2018-01-17 |
|
| 6 |
Chu Yu-waye |
Chief Medical Officer |
140,676 |
2023-04-19 |
|
| 7 |
Plavsic Mark |
Chief Technical Officer |
123,705 |
2023-01-11 |
|
| 8 |
Abernethy Matt |
Director |
110,000 |
2025-05-30 |
|
| 9 |
Dulac Edward J Iii |
Chief Financial Officer |
101,479 |
2024-03-05 |
|
| 10 |
Adawi Kamal |
Chief Financial Officer |
75,000 |
2026-01-16 |
|
| 11 |
Shoemaker Daniel D |
Chief Scientific Officer |
73,020 |
2021-03-09 |
|
| 12 |
Agarwal Shefali |
Director |
55,000 |
2025-05-30 |
|
| 13 |
Mendlein John |
Director |
55,000 |
2025-05-30 |
|
| 14 |
Epstein Robert S |
Director |
55,000 |
2025-05-30 |
|
| 15 |
Lee Michael Stewart |
Director |
55,000 |
2025-05-30 |
|
| 16 |
Redmile Group, Llc |
10 Percent Owner |
55,000 |
2025-05-30 |
|
| 17 |
Mozaffarian Neelufar |
Director |
55,000 |
2025-05-30 |
|
| 18 |
Jooss Karin |
Director |
55,000 |
2025-05-30 |
|
| 19 |
Rastetter William H |
Director |
55,000 |
2025-05-30 |
|
| 20 |
Xu Yuan |
Director |
55,000 |
2025-05-30 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-01-15 |
Adawi Kamal |
Chief Financial Officer |
RSU-Zuteilung |
75,000 |
$1.05 |
$78.75K |
| 2026-01-15 |
Valamehr Bahram |
President and CEO |
RSU-Zuteilung |
335,000 |
- |
- |
| 2026-01-15 |
Tahl Cindy |
See Remarks |
RSU-Zuteilung |
400,000 |
$1.05 |
$420K |
| 2026-01-09 |
Valamehr Bahram |
President and CEO |
Informierter Verkauf |
5,190 |
$1.07 |
$5.56K |
| 2026-01-09 |
Tahl Cindy |
See Remarks |
Informierter Verkauf |
10,589 |
$1.06 |
$11.28K |
| 2025-10-20 |
Adawi Kamal |
Chief Financial Officer |
RSU-Zuteilung |
75,000 |
- |
- |
| 2025-10-20 |
Adawi Kamal |
Officer |
Unbekannt |
- |
- |
- |
| 2025-08-04 |
Valamehr Bahram |
President and CEO |
Informierter Verkauf |
14,466 |
$1.06 |
$15.4K |
| 2025-08-04 |
Tahl Cindy |
See Remarks |
Informierter Verkauf |
9,037 |
$1.06 |
$9.57K |
| 2025-07-02 |
Redco Ii Master Fund, L.p. |
10 Percent Owner |
Unbekannt |
3,691,324 |
- |
- |
| 2025-05-29 |
Mozaffarian Neelufar |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Xu Yuan |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Jooss Karin |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Lee Michael Stewart |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Agarwal Shefali |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Abernethy Matt |
Director |
RSU-Zuteilung |
110,000 |
$1.32 |
$145.2K |
| 2025-05-29 |
Abernethy Matt |
Officer |
Unbekannt |
- |
- |
- |
| 2025-05-29 |
Redmile Group, Llc |
10 Percent Owner |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Epstein Robert S |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Mendlein John |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
| 2025-05-29 |
Rastetter William H |
Director |
RSU-Zuteilung |
55,000 |
$1.32 |
$72.6K |
